Human vascular endothelial cells (HUVECsl, which do not display the lipopolysaccharide (LPS) receptor CD14, were examined for protein tyrosine phosphorylation after LPS stimulation in the presence and absence of soluble CD14 (sCD14). By phosphotyrosine Western blotting and immunocomplex kinase assays we show that LPS was capable of inducing in these cells rapid protein tyrosine phosphorylation and kinase activation of two members of the mitogenactivated protein kinase (MAPKI family erk-l and the newly discovered p38, requiring the presence of sCD14. LPS-induced tyrosine phosphorylation of MAPK was associated IPOPOLYSACCHARIDE (LPS)-recognition and signal transmission are key events in the host defense reaction towards pathogenic Gram-negative bacteria.' LPS, an integral part of the bacterial cell wall, represents one of the strongest stimulators for many cell types in the body and has proven to be responsible for tissue and organ damage during Gram-negative septicemia and septic shock.'
It has been shown early that adhesiveness of ECs for leukocytes changes dramatically during inflammatory processes and that these cells release tissue factor and cytokines on LPS-stirnulatiom8"' The activated or injured endothelial cells play a pivotal role in local tissue damage and repair, in the "capillary leak syndrome," "disseminated intravascular coagulation," and in "multi-organ-failure,'' which are elements in the pathogenesis of sepsis."." ECs, for instance, have been shown to respond to LPS-stimulation by producing interleukins (ILs), growth factors, and NO, by expressing adhesion molecules, and by activating NF-KB.'~ Overstimulation of myeloid and stroma cells for cytokine release and expression of adhesion molecules by LPS, as it occurs during endotoxemia and sepsis, appears to play a pathogenic role in the onset and course of this disease. Research aimed at elucidating the mechanisms of endotoxinrecognition, uptake, and signaling, has thus been lived up during the past years, to further elucidate the cascade of events leading to septic shock, and to potentially develop novel intervention strategies. Several elements of endotoxin recognition have been identified by different groups, including ourselves: Endotoxin first forms a complex with the acute-phase protein lipopolysaccharide binding protein (LBP)I4.l5 then binds to the cellular LPS-receptor CD14,'6. ' vated protein kinase (MAPK) family in monocytes," including a novel 38-kD MAPK also termed "cytokine suppressor binding protein" (CSBP) that was recently isolated and cloned." This protein appears to be a major target for endotoxin-effects, shares high homology with a yeast protein conferring resistance to hyperosmolarity, and is inhibited by a novel bicyclic imidazole termed "cytokine suppressive antiinflammatory drug" (CSAID).*'
The LPS-responses of CD14-stroma cells were shown to require the presence of soluble CD14 (sCD14), that directs LPS to CD14-cell^.'^ As surface CD14 is attached to the cell membrane by a phosphatidyl-inositol (PI)-anchor and does not display a transmembrane domain, a co-receptor was postulated, which acts as primary LPS-acceptor on CD14-cells. Until now, little is known on LPS-mediated signal transduction in CD14-cells such as ECs. We here report on LPS-induced signaling events in HUVECs by focusing on tyrosine phosphorylation and activation of MAPKs. rinsed repeatedly with PBS. A 0.05% trypsin/0.02% EDTA solution was inoculated and kept within the vein at 37°C. After 15 minutes cells were collected by releasing the trypsin solution, which was neutralized by addition of 10 mL medium M199, supplemented with 20% fetal calf serum (FCS), followed by repeated washings with PBS. Cells were taken into 1 % gelatin-coated plastic dishes (Nunc, Renner, Dannstadt, Germany) and kept at 37°C in a humidified atmosphere of 5% CO2 in air. For long-term HUVEC culture, culture medium consisted of medium M199, supplemented with 20% FCS, 90 pg/mL heparin, 1% penicillidstreptomycin, 1 % glutamine, 30 pg/ mL endothelial cell growth supplement (ECGS), and 0.5% "biotectprotection-medium." The endothelial cells exhibited the typical cobblestone feature and were greater than 98% positive for factor VIII, as was shown by fluorescence-activated cell sorter (FACS) analysis using anti-von Willebrand factor IgG. When cells were confluent, they were briefly incubated with 2.5% trypsin, neutralized by addition of complete medium, collected by centrifugation with 800g and split l:3. Second to fourth passage cells were used for experimentation. Confluent monolayers were rinsed twice with serum-free medium MI99 and kept serum-deprived for 1 hour before stimulation.
For stimulation, cells were exposed to different concentrations of Salmonella minnesota Re595 LPS, Lipid A, or monophosphoryl Lipid A for varying periods of time in the presence or absence of 10% human AB-serum (Sigma, St Louis, MO), containing 1.5 pg/ mL sCD14 (as detected by sCD14 enzyme-linked immunosorbent assay ELISA) and no detectable LPS (by LAL-assay). The CD14 content of the serum was 5 pg/mL, as determined by a sCD14
ELISA-assay. After stimulation, cells were washed with ice-cold PBS Dulbecco's solution containing 1 mmol/L Na3V04, followed by addition of 100 pL lysis buffer, containing I% Triton X-l00 (Roth CO, Karlsruhe, Germany), 20 mmoVL Tris-HCI, pH 8.0, 137 mmol/L NaCI, 10% glycerol, 1 mmol/L Na3V04, 2 mmoVL EDTA, 2 mmol/L EGTA, 1 m m o K phenylmethanesulfonyl fluoride, 20 pmol/L leupeptin, and 0.15 U/mL aprotinin. Cells were immediately scraped off the plate and the lysate was placed on ice for 20 minutes followed by a centrifugation at 10,OOOg for 15 minutes at 4°C. The postmitochondrial supernatant fraction was removed and stored at -80°C. CDl4-blocking, inhibitors of tyrosine phosphorylation. Medium containing human AB-serum was blocked for soluble CD14-activity as follows: The murine monoclonal antibody (MoAb) My-4 was added at 2.5 pg/mL and incubated 30 minutes before experimentation and before adding stimulatory agents. For blocking of tyrosine phosphorylation, inhibitors were added to the medium and cells were preincubated for 3 hours. The concentrations of inhibitors were 50 pmol/L Tyrphostin 25, and 80 pmol/L Genistein.
Antiphosphotyrosine ELISA and immunoblotting. After activation, cell lysates were examined for equal amounts of protein by the Bradford method using bovine serum albumin (BSA) as standard." Then samples, stimulated for 15 minutes with LPS, were tested for overall cellular tyrosine phosphorylation with the "tyroscan" kit (Laboserv, Geissen, Germany) according to manufacturer's guidelines. Briefly, 20 and 150 ng, respectively, of lysates were placed on a 96-well plate precoated with tyrosine residues poly (Glu, Tyr) as substrate for kinase activity. Detection of tyrosine phosphorylation was performed with a MoAb, followed by a peroxidase-coupled antibody and colorimetric detection. The color-reaction was read in a Milenia kinetic analyzer (Diagnostic Products Corp. LOS Angeles, CA) at 450 nm OD. Samples of 20 pg or 30 pg, respectively, of cellular protein were prepared for electrophoresis by mixing with concentrated sample buffer to obtain a final concentration of 50 m m o K Tris-HC1, pH 6.8, 2% sodium dodecyl-sulfate (SDS), 100 mmol/L DTT, 10% glycerol, and 0.1% bromophenol blue. Samples were separated on a 10, or 13% SDS-polyacrylamide gel (PAGE), respectively, using a Tris-buffer system as described." After electrophoresis, the gel was immersed in transfer buffer, containing 4X mmol/L Tris, 39 mmol/L glycine, and 0.037% SDS for S minutes and transferred to a "Hybond-C extra" membrane (Amersham. Braunschweig, Germany) by a "semi-dry" blotting apparatus (Hdlzel GmbH, Dorfen, Germany) at I mA/cm' for 90 minutes. Before the immune reaction, membranes were blocked with 5% BSA in
Tris-buffered saline with 0.1% Tween 20 (TBST), overnight at 4°C. The membranes then were washed, according to manufacturer's instructions and incubated with 0.5 pg/mL 4G10, diluted in TBST containing 1 % BSA for 2 hours at room temperature. After washing, the membranes were incubated with horseradish peroxidase-linked protein-A, diluted 15,000 in TBS, containing 1 % BSA for 90 minutes at room temperature. After a final washing, the immunoreactive blots were detected with the "ECL-system," according to manufacturer's instructions and visualized on "Hypertilm-ECL-films" (Amersham) by chemoluminescencc. Immunr)precipitation with anti-erk-l, -erk-2, and -p38 antihodius. One hundred micrograms of cellular proteins were diluted with lysis buffer (previously described) to a volume of 500 pL, and incubated with the antibodies. Five micrograms of anti-erk I -CT-and anti-erk-2 antibody and 5 p L of the anti-p38 peptide antibody were used. The immune complexes were precipitated by addition of 20 pL protein-MG-plus agarose, and incubation overnight at 4°C. The beads were collected by centrifugation for 15 minutes at 3000~. washed once with lysis buffer (previously described) and once with reaction assay buffer (previously described), before the beads were resuspended in sample buffer (previously described) for electrophoresis. SDS-PAGE using a 13% SDS gel, transfer to nitrocellulose membranes and blocking were performed as previously described.
The specific antibodies were used 1:5,000 to 1:10,000. After washing, the membranes were incubated with horseradish peroxidaselinked protein-A, diluted 1:5,OOO in TBS, containing 1% BSA for 90 minutes at room temperature. After a final washing, the immunoreactive blots were detected with the "ECL-system," according to manufacturer's instructions and visualized on "Hyperfilm-ECLfilms" (Amersham) by chemoluminescence. After one reaction. membranes were stripped by incubation with 2% SDS, 62.5 mmol/L Tris, pH 6.7, 100 mmoVL DTT for 30 minutes at 70°C and reprobed.
Irnrnunocomplex kinase assay using myelin basic protein ( M E P ) as substrate and the "Biotrak MAPK assay system. " Aliquots of 2 pg of postmitochondrial supernatant or resuspended beads with immunoprecipitated proteins (previously described) were analyzed for MBP phosphotransferase activity according to a published protocol.>' Briefly, 13.5 pL of the kinase reaction mixture, consisting of reaction assay buffer (50 mmoVL HEPES, pH 7.4, 20 mmoUL MgCI2, and 50 pmol/L adenosine triphosphate [ATP], supplemented with 2 yCi [y-"P] ATP, and 12.5 pg MBP was added to the sample and allowed to react for 10 minutes at 30°C. The reaction was terminated by addition of concentrated sample buffer, containing S0 mmol/L Tris-HCI, pH 6.8, 2% SDS, 100 mmol/L dithiothreitol ( D m ) , 10% glycerol, and 0.1% bromophenol blue. Probes were denaturated for 3 minutes and separated on a 13%' SDS-PAGE. Kinase activity was determined and visualized with a Fuji-X-Bioimaging-analyzer BAS 2000 (Fuji, Dusseldorf, Germany) or on Kodak X-ray films (Eastman Kodak, Rochester, NY). Additionally the Biotrak system (Amersham Life Science, Braunschweig, Germany) was employed according to the manufacturer's instructions. Briefly, here cellular lysates, prepared as previously described, are incubated in the presence of [y-'*P] ATP with a peptide highly selective for p42/p44 MAPKs. The incubation proceeds for 30 minutes and the peptide is separated from unincorporated activity using a binding paper separation step. Incorporated radioactive ATP is measured in a scintillation counter and the amount of radioactivity corresponds to the MAPK activity.
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From Analysis of surface expression of intercellular adhesion molecule (ICAM-1) and CD14. For analysis of ICAM-1-and CD14 surface expression, endothelial cells were gently detached from tissue culture plastic by incubation with PBS containing 1 mmollL EDTA for 60 minutes at 37°C. After repeated washings, lo6 cells were incubated with the first (specific) antibody (sources given below) for 1 hour at 4°C. After repeated washings, incubation with a fluorescein isothiocyanate (FITC) conjugated IgG for 30 minutes at 4°C in the dark was performed. The cells were fixed in PBS containing 0.5% formalin and cell analysis was performed with a FACScan using Lysys I1 software (both from Becton Dickinson, San Jose, CA).
Northern blotting, cDNA probes. HUVECs were grown to confluency, stimulated as previously described, and total cellular RNA was isolated from selected plates with the "RNeasy"-kit (QIAGEN, Hilden, Germany), according to manufacturer's instructions. RNA was washed twice with 80% ethanol, and equal amounts of 15 pg were loaded onto each lane of a 1% agarose gel, prepared in 40 mmol/L Tris acetate, 1 mmoVL EDTA buffer, pH 8.0 (1 X TAE). Five microliters of the concentrated samples were mixed with 25 pL of sample buffer, consisting of MOPS-buffer,26 supplemented with 16% formaldehyde, 52% formamide, and 5 mg/mL bromophenol blue. Electrophoresis was performed at 6 V/cm gel for -2 hours. The RNA was transferred to a Hybond N+ Membrane (Amersham) by vacuum blotting with a Vacugene 2016 apparatus (Pbarmacia, formerly LKB, Freiburg, Germany) in 20X SSC (3 moVL NaC1, 300 mmom Na citrate, pH 7.0) or as dot-blot, manually. The blots were immobilized by UV-irradiation with the Stratalinker 1800 (Stratagene, Heidelberg, Germany), prehybridized in a buffer containing 6X SSC (0.9 mom NaCl, 0.09 m o m Na citrate), 5X Denhardt's solution?' 0.5% SDS, and 30 pg/mL salmon sperm DNA for 3 hours at 68°C. Hybridization was performed in a solution containing 6X SSC, 0.5% SDS, 50% formamide and 10 pg/mL salmon sperm DNA, supplemented with [a-"P] dCTP-labeled DNA probes overnight at 42°C. The ICAM-I-and GAPDH-probes were made from cDNA clones, obtained from the American Type Culture Collection (ATCC). The 1.3 kB labeled ICAM-1 fragment was obtained by 40 cycles of polymerase chain reaction (PCR) using the full-length cDNA as template. The 1 kB GAPDH-probe resulted from a PSTI digest, followed by PCR labeling. The resulting probes had an activity of -lo6 counts/mL. After hybridization, the blots were washed with 2 x SSC, 0.5% SDS, followed by 2 x SSC, 0.1% SDS, and 0 . 1~ SSC, 0.5% SDS. Filters were exposed to Kodak X-ray films for 1 to 2 days at -80°C using intensifying screens or visualized with a FujiBio imaging analyzer (Fuji, Diisseldorf, Germany).
Chemicals and culture reagents. Trypsin, L-glutamate, penicillin, streptomycin, and PBS Dulbecco's solution were from GIBCO BRL, Life Technologies GmbH, Eggenstein, Germany. Sodiumpyruvate, EDTA, and "biotect-protection-medium" were purchased from Biochrom KG, Berlin, Germany. Lipid A and monophosphoryl Lipid A were from ICN Biomedicals GmbH, Meckenheim, Germany. Herbimycin A, Tyrphostin 25, and Genistein were purchased from Calbiochem GmbH, Bad Sonden, Germany. Horseradish peroxidase-linked protein-A was from Amersham Buchler, Braunschweig, Germany. Salmonella minnesota Re 595 LPS, anti-von Willebrand factor antiserum, heparin, medium M199, FCS, human AB serum, and endothelial cell growth supplement were from Sigma-Aldrich, Deisenhofen, Germany. [a-P3'] dCTP, and [yP3'] ATP were purchased from Du Pont de Nemours GmbH, Bad Homburg, Germany. FITC-conjugated "affi-pure" sheep anti-mouse IgG (H + L) was purchased from Jackson Immuno Research Laboratories, Inc (Dianova, Hamburg, Germany). The ICAM-l-MoAb was obtained through Immunotech SA, Marseille, France (anti-ICAM-l, clone 84H10). The antiphosphotyrosine antibody 4G10, and the rabbit polyclonal anti-MAPK antiserum (anti-erk-l-CT) were from Biomol Feinchemikalien GmbH, Hamburg, Germany. The rabbit poly- clonal anti erk-2 antiserum erk-2 (C-14) and the protein-A/G plus agarose was from Santa Cruz Biotechnology, Inc (Santa Cruz, CA). The anti-p38 peptide antibody was a kind gift of Dr R.J. Ulevitch (The Scripps Research Institute, La Jolla, CA). The anti-CD14 MoAb MY4 was from Coulter (Heidelberg, Germany).
RESULTS

LPS induces [CAM-1 expression in
HUVECs in the absence of surface CD14 expression. We first examined freshly isolated HUVECs, characterized by von Willebrand factor expression and typical cobblestone morphology (not shown) for surface expression of the LPS-receptor CD14. As shown in Table 1 , HUVECs failed to display surface CD14 using flow cytometry analysis and specific MoAbs. As positive control, the myeloid cell line THP-1 was examined, which exhibits moderate constitutive CD14-surface expression that could be further enhanced by addition of Vitamin Dj, leading to a 12-fold higher ICAM-1 expression as compared to unstimulated THP-1.
To examine whether LPS and its active compound Lipid-A were capable of stimulating HUVECs for increased ICAM-1 expression, an in vitro system was set up which contained serum as a source of sCD14. ICAM-l expression was assessed at the mRNA and protein level by Northern blot analysis and flow cytometry. LPS, Lipid A, and the Lipid A-derivative monophosphoryl Lipid A (MPLA), shown to be less active as compared to native Lipid A in other assays,'* were used to stimulate ICAM-l expression by HUVECs.
In a dose-response experiment performed as dot-blot analysis, shown in Fig lA, as little as 10 ng/mL of LPS induced ICAM-1 expression that could be further enhanced by increasing the LPS-dose to 100 ng/mL. These LPS concentrations relate to levels found in serum during diseases caused by Gram-negative ba~teria.'~.~~ Higher concentrations were shown to decrease HUVEC activation, as has been shown by other^.^' GAPDH, as a control was also slightly induced by LPS, however, the ICAM response was much more pronounced. As expected, MPLA and Lipid A, used 10-times more concentrated than LPS, also induced ICAM-l transcript accumulation, whereby the hybridization signal was much weaker as compared to the LPS-stimulated culture ( Fig   For personal 
ties were used and the assay was performed with two different protein amounts (20 and 150 ng, respectively). Table 2 shows that stimulation of HUVECs with IO ng/mL LPS enhanced the overall tyrosine phosphorylation -2.4-foId, whereas at higher amounts (1 pg/mL) LPS-inducible increase in tyrosine phosphorylation appeared to be lost. The latter result may indicate a toxic effect of LPS towards ECs, which was also reproduced in other assays (discussed later). Because different amounts of protein gave comparable results in the "tyroscan"-assay this experimental approach appeared to be reproducible.
To determine size and specificity of HWEC-derived proteins that were tyrosine phosphorylated upon LPS-stimulation, a phosphotyrosine Western blot with cellular lysates and the antiphosphotyrosine MoAb 4G10 was instrumental. Figure 3 shows the results of the Western analysis detected with the ECL-system. Shown is a dose-dependent increase in tyrosine phosphorylation of a protein of -44 kD in size. as well as a weaker increase of two additional proteins of 40 and 42 kD in size. An increase in phosphorylation of the 44-kD protein was seen with LPS concentrations as little as 30 ng/mL LPS, which further increased when up to 300 ng/ mL LPS were used. However, with 1 pg/mL, this effect was reversed as was expected from the results seen in the "tyroscan" assay.
Iderrt+cation of LPS-dependent tyrosine phos~?honlntiorr
of erk-l nrld p38. To identify the strongly inducible 44-kD band and the two smaller bands, seen in the antiphosphotyrosine Western blot, immunoprecipitation experiments were performed. As these three bands potentially comigrate with the MAPKs erk-l, erk-2, and the recently identified p38-MAPK,??.'? immunoprecipitation experiments were performed using specific antibodies against these three proteins. The results of these experiments are shown in Fig 4. Immunoprecipitation with the anti-MAPK antibody anti- The anti-erk-l antibody also appeared to detect a 42-kD band. It was reported by the manufacturers that this antibody also detects erk-2 to a lesser degree (and a third protein). However, when we performed a similar immunoprecipitation experiment with a specific anti-erk-2 antibody (erk-2 C-14). we could not detect a tyrosine phosphorylated protein in the MBP-phosphorylation was measured as described in the Materials and Methods section. The arbitrary units obtained from autoradiography scanning were divided by the amount of protein used in the assay, leading to the values shown.
t Immunoprecipitation was performed with the anti-erk-l CT antibody as described in the Materials and Methods section. The remaining supernatant was used as MAPK-depleted lysate.
plex kinase assay, where phosphorylated MBP is visualized by autoradiography and quantified by densitometry. As shown in Fig 5A, a slight increase in kinase activity was seen as early as 5 minutes after stimulation with 100 ng/mL of LPS. After 15 minutes, levels of MBP-phosphotransferase activity were almost twice as high as background levels (arbitrarily set as "l"). A complete time-course of MAPK activity after LPS stimulation (100 ng/mL), measured with the Biotrak MAPK assay is shown in 5B: It can be seen that after a sharp increase, MBP phosphorylation decreased 15 minutes after LPS stimulation and returned to almost baseline levels after 60 minutes.
Next, the MBP-phosphorylation activity was investigated in MAPK-precipitates and MAPK-depleted lysates and compared to total lysate of unstimulated and 100 ng/mL LPSstimulated HUVECs. The results, shown in Table 3 , indicate that MAPK-depletion strongly reduces MBP-phosphorylation activity in cell lysates, whereas the MAPK-precipitates exhibit a strong inducibility by LPS. To further specify these signaling events, the next set of experiments aimed at specifically inhibiting LPS-induced signaling in HUVECs.
An MoAb to CD14 blocks MBP-phosphorylation of HWECs induced by LPS. ECs do not display surface CD 14. Nevertheless, it has been suggested that LPS may exert effects on HUVECs most likely mediated by soluble CD14, commonly present in serum. To further assess the specificity of our reaction complex, we preincubated serum-containing medium with an anti-CD14 MoAb, or, as a control, with a monoclonal anti-HLA-DR antibody, respectively. Fig 6 shows that preincubation of medium with anti-CD14 substantially reduced LPSinduced MBP-phosphorylation, whereas the control antibody had no effect, but rather slightly enhanced the LPS-induced increase. In addition, experiments were performed in a serumfree system, which did not exhibit any LPS-induced kinase activity but could be reconstituted with recombinant soluble CD14 (5 pg/mL, not shown). These results confirm that soluble CD14 participates in LPS-recognition and -transmission, leading to tyrosine phosphorylation of MAPKs.
Partial inhibition of LPS-induced MBP-phosphorylation by tyrosine phosphorylation inhibitors. To assess whether the LPS-induced tyrosine phosphorylation of MAPKs could be relieved by known inhibitors, we first added two known ited weak inhibiting activities whereas Genistein blocked more than 50% of LPS-inducible kinase activity at 80 pmol/ L. We furthermore performed dose-response experiments, using the Biotrak MAPK assay. The results, as shown in Fig  7B, show that a clear dose-dependent inhibition of MAPK activity can be seen, however, the reduction does not go beyond 50%. To rule out any cytotoxic effect of these compounds, we performed cytotoxicity assays, measuring total cellular protein content and trypan blue exclusion. As shown in Table 4 , no cytotoxic effect could be observed at 50 pmol/ L Tyrphostin or 80 pmoVL Genistein, two concentrations that clearly showed inhibition of MAPK activity. Although this blocking-pattern was weaker than expected, it confirms that tyrosine phosphorylation and subsequent increased MBP-phosphorylation activity is involved in HUVEC stimulation. However, other signaling pathways, may also contribute to LPS-induced kinase activation in HUVECs. In pilot experiments (not shown here) Genistein and Tyrphostin 25 were capable of blocking, in synergy with the PKC-inhibitor H7, LPS-induced ICAM-expression in the EC line ECV 304. These data, taken together with the data reported here, give evidence for a novel, not yet recognized participation of tyrosine phosphorylation in LPS-induced activation of HUVECs. More information on this issue are to be expected from the use of erk-l and p38 dominant negative mutants transfected into HUVECs that will allow an estimate of the relative contribution of MAPK phosphorylatiodactivation to LPS-induced upregulation of ICAM-l. These experiments are currently in progress in our laboratory. The EC that represents the borderline between the intraand extravascular space is a highly specialized cell centrally involved in physiologic and pathologic processes such as angiogenesis, wound healing, and initiation of local inflammation and For any circulating cell to migrate into the surrounding tissue, adhesion molecule-mediated contact to endothelium has to be established for diapedesis through the EC layer to O C C U~.~~.~' Activation and stimulation of the EC have to be tightly regulated and insights into these mechanisms are of particular importance for many physiologic and pathological During sepsisrelated syndroms like the "capillary leak syndrome" and "disseminated intravascular coagulation," the EC potentially plays a pathogenically important ro1e.""~4j In these states, the homeostasis of the endothelium is disturbed following entry of pathogenic bacterial compounds into the blood stream, binding to ECs and initiation of cellular responses after signaling."' Elucidating regulatory mechanisms of EC activation is thus expected not only to improve our understanding of certain diseases, but also to contribute to the development of novel therapeutic intervention strategies.
So far, LPS-mediated activation of ECs and signal trans- duction has mainly been linked to protein kinase C (PKC) and calcium-mediated A recent study by Yang et a1: ' using bovine EC lines, failed to show LPS-induced tyrosine phosphorylation because blocking agents were not able to inhibit LPS-induced tissue factor production. However, substantial differences to the study presented here, may SCHUMANN ET AL exist: The dose of Genistein, the strongest inhibitor seen in our study, was relatively low in the study by Yang et al. Moreover, these experiments were performed with endothelial cell lines, known to behave differently as compared to freshly isolated HUVECs used in our study. In our hands, the endothelial cell line ECV 304 also showed much weaker biological responses to LPS (not shown). The studies presented here do not exclude involvement of PKC-pathways in LPS-signaling. However, we give evidence to suggest that protein tyrosine phosphorylation of MAPKs also plays a role in LPS-mediated effects on HUVECs. The effects observed by us are moderate and it is likely that several converging signaling pathways may be used by LPS to fully activate ECs. Also, our data do not answer whether seridthreonine phosphorylation is additionally involved in cell activation. However, we have evidence that tyrosine phosphorylation is not just constitutive but appears to be involved in cell activation. In the ECV 304 cell line, we observed an additive effect of the PKC inhibitor H7 and tyrosine phosphorylation inhibitors to block LPS-induced ICAM-l expression (not shown), further supporting the hypothesis of several signaling pathways acting in concert to mediate LPS-responses in the EC.
Our data give also evidence for a similar signal transducing receptor element, acting in cooperation with surface or soluble CD14 on CD14-positive and -negative cells, because signaling elements involved in LPS-signaling in HUVECs were found to be similar to those seen in CD14' macrophages. For macrophages, tyrosine phosphorylation of MAPK was shown to be involved in LPS-mediated cell activation?'.3'. 36 In these studies, a novel member of the MAPK family was identified and shown to be a major target of LPS-induced activation of myelo-monocytic cells.2'.22.3' This kinase, called p38, or CSBP, was found in different electrophoresis systems to migrate as 38 to 40 kD bands. We here show that the minor protein found by us to be phosphorylated in response to LPS, represents this novel p38 MAPK. A participation of this kinase in EC activation will have to be proven by addition of the specific inhibitor CSAID to our experimental system, which is currently underway.
Moreover, our data suggest that blocking of tyrosine phosphorylation in vivo, which was shown to dramatically increase animal survival in an in vivo sepsis model:' could at least in part be related to a protective effect of tyrosine phosphorylation inhibition in ECs. It becomes more and more evident that endotoxin also exhibits direct effects on ECs and acts not only via paracrine stimulation of phagocytes for release of proinflammatory cytokines like IL-l and tumor necrosis factor (TNF), which in turn stimulate ECs. This might also be one explanation among others, why the blockade of proinflammatory cytokine in sepsis by compounds such as IL-l receptor antagonist or soluble TNF receptors failed to reduce sepsis mortality in clinical studies.'" Possibly, the cascade of events leading to the clinical manifestation of septic shock has to be blocked at an earlier stage, and not when myelo-monocytic cells are already induced for cytokine release, to protect the endothelium and thus to prevent the clinical onset of sepsis.
The induction of the tyrosine phosphorylation of MAPK For personal use only. on October 27, 2017. by guest www.bloodjournal.org From appears to be a general pattern of LPS-action towards host cells and might be a potential target to experimentally block LPS-effects, as was recently proposed and succesfully transferred to the animal m0de1.4~ However, in ECs, involvement of this pathway appears to be weaker as compared to the effects seen in monocytes/macrophages, and a combined PKC-and MAPK-inhibition is thus expected to be more effective in blocking LPS-effects.
